Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.04 HKD | -2.51% | +6.11% | -24.10% |
02/05 | Alphamab Oncology's 2023 Loss Narrows as Revenue Rises | MT |
10/04 | Alphamab Oncology Presents Phase-I Clinical Trial Results at 2024 AACR Annual Meeting | MT |
Business Summary
Number of employees: 435
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biologics of Oncology
100.0
%
| 194 | 100.0 % | 242 | 100.0 % | +24.60% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 194 | 100.0 % | 242 | 100.0 % | +24.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ting Xu
CEO | Chief Executive Officer | 51 | 01/08/01 |
Jing Han
CMP | Compliance Officer | 51 | 02/21/02 |
Jinbo Wang
CTO | Chief Tech/Sci/R&D Officer | 50 | 19/18/19 |
Liang Kong
CTO | Chief Tech/Sci/R&D Officer | 44 | 01/18/01 |
Lu Amy Sun
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/19/01 |
Yang Liu
COO | Chief Operating Officer | 52 | 01/18/01 |
Jin Nan Wang
IRC | Investor Relations Contact | 42 | - |
Shaowei Yang
PRN | Corporate Officer/Principal | 48 | 13/17/13 |
Mike Liu
PRN | Corporate Officer/Principal | 58 | 01/18/01 |
Lok Yee Chan
SEC | Corporate Secretary | 35 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Wei
BRD | Director/Board Member | 56 | 24/19/24 |
Ting Xu
CEO | Chief Executive Officer | 51 | 01/08/01 |
Yang Liu
COO | Chief Operating Officer | 52 | 01/18/01 |
Dong Wu
BRD | Director/Board Member | 54 | 24/19/24 |
Zijian Guo
BRD | Director/Board Member | 63 | 27/21/27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 964,843,807 | 474,790,857 ( 49.21 %) | 0 | 49.21 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.10% | 638M | |
+22.81% | 46.81B | |
+47.02% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |
- Stock Market
- Equities
- 9966 Stock
- Company Alphamab Oncology